# Expanded Access for BLZ-100 (Tozuleristide)

Source: https://onco.cc/trials/nct04343274/  
OnCo record `nct04343274` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

An trial of Tozuleristide run by Blaze Bioscience Inc., registered.

## Summary

Expanded Access for BLZ-100 (Tozuleristide) is an interventional study registered as NCT04343274 by Blaze Bioscience Inc.. Conditions recorded: not stated. Interventions recorded: Tozuleristide.

## Fields

- Kind: Trial
- Status: active
- Last checked: 2026-11-03
- Tags: pipeline; ctgov-ingest
- Registry id: NCT04343274
- Phase: not-applicable
- Setting: Expanded Access for BLZ-100 (Tozuleristide)
- Sponsor: Blaze Bioscience Inc.

## Sources

- ClinicalTrials.gov NCT04343274: https://clinicaltrials.gov/study/NCT04343274

## Connected records

- drugs: [Tozuleristide](https://onco.cc/drugs/blz-100/)
- companies: [Blaze Bioscience](https://onco.cc/companies/blaze-bioscience/)

---
JSON: https://onco.cc/api/v1/entities/nct04343274.json